Predicting outcomes in men with metastatic nonseminomatous germ cell tumors (NSGCT): results from the IGCCCG update consortium

…, M Chovanec, E Winquist, P Grimison… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The classification of the International Germ Cell Cancer Collaborative Group (IGCCCG)
plays a pivotal role in the management of metastatic germ cell tumors but relies on …

Precision medicine for advanced pancreas cancer: the individualized molecular pancreatic cancer therapy (IMPaCT) trial

…, S Yip, N Pavlakis, R Asghari, S Harvey, P Grimison… - Clinical cancer …, 2015 - AACR
Purpose: Personalized medicine strategies using genomic profiling are particularly
pertinent for pancreas cancer. The Individualized Molecular Pancreatic Cancer Therapy (IMPaCT) …

Clinical pathway for the screening, assessment and management of anxiety and depression in adult cancer patients: Australian guidelines

…, JM Shaw, J Turner, JM Clayton, P Grimison… - Psycho …, 2015 - Wiley Online Library
Purpose A clinical pathway for anxiety and depression in adult cancer patients was developed
to guide best practice in Australia. Methods The pathway was based on a rapid review of …

Survival and new prognosticators in metastatic seminoma: results from the IGCCCG-update consortium

…, C Fankhauser, D Stark, P Grimison… - Journal of clinical …, 2021 - ascopubs.org
PURPOSE The classification of the International Germ-Cell Cancer Collaborative Group (IGCCCG)
has been a major advance in the management of germ-cell tumors, but relies on data …

Capecitabine versus classical cyclophosphamide, methotrexate, and fluorouracil as first-line chemotherapy for advanced breast cancer

…, G Van Hazel, NRC Wilcken, PS Grimison… - Journal of clinical …, 2011 - ascopubs.org
Purpose We compared oral capecitabine, administered intermittently or continuously,
versus classical cyclophosphamide, methotrexate, and fluorouracil (CMF) as first-line …

Active surveillance is the preferred approach to clinical stage I testicular cancer

…, K Fizazi, B Hayes-Lattin, P Grimison… - Journal of Clinical …, 2013 - ascopubs.org
A simple framing statement is needed to consolidate decision making and guide management
for the most common setting in testicular cancer. 1 Clinical stage I (CSI) testicular cancer is…

Hemoglobin, body mass index, and age as risk factors for paclitaxel-and oxaliplatin-induced peripheral neuropathy

…, D Wyld, RD Henderson, P Grimison… - JAMA network …, 2021 - jamanetwork.com
Importance Chemotherapy-induced peripheral neuropathy (CIPN) is a debilitating adverse
effect of neurotoxic cancer treatments including taxanes and platinum agents. Limited …

QLU-C10D: a health state classification system for a multi-attribute utility measure based on the EORTC QLQ-C30

…, JE Brazier, DF Cella, PM Fayers, P Grimison… - Quality of Life …, 2016 - Springer
Purpose To derive a health state classification system (HSCS) from the cancer-specific
quality of life questionnaire, the EORTC QLQ-C30, as the basis for a multi-attribute utility …

First-in-human study of oleclumab, a potent, selective anti-CD73 monoclonal antibody, alone or in combination with durvalumab in patients with advanced solid …

…, SW Kim, S Clarke, TJ George, PS Grimison… - Cancer Immunology …, 2023 - Springer
Background CD73 upregulation in tumors leads to local immunosuppression. This phase I,
first-in-human study evaluated oleclumab (MEDI9447), an anti-CD73 human IgG1λ …

The prevalence and correlates of supportive care needs in testicular cancer survivors: a cross‐sectional study

…, M King, P Butow, T Luckett, P Grimison… - Psycho …, 2013 - Wiley Online Library
Objective This cross‐sectional study aimed to identify the prevalence and correlates of
supportive care needs in testicular cancer (TC) survivors. Methods Men who had completed …